High prevalence of small dense LDL in diabetic nephropathy is not directly associated with kidney damage: A possible role of postprandial lipemia

Atherosclerosis

Volumn 141, Issue 1, 1998, Pages 77-85

  Hirano, Tsutomu ^a   Oi, Keiko ^b   Sakai, Soichi ^b   Kashiwazaki, Koichi ^a   Adachi, Mitsuru ^a   Yoshino, Gen ^b  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Diabetic nephropathy; Postprandial lipemia; Renal disease; Small dense LDL; Triglyceride

Indexed keywords

LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC NEPHROPATHY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HEMODIALYSIS; HUMAN; HYPERLIPIDEMIA; KIDNEY INJURY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032487562     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00150-6     Document Type: Article

References (30)

1. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction JAMA. 260:1988;1917-1921.
2. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
3. Barakat HA, Carpenter JW, McLendon VD, Khazanie P, Leggett N, Heath J, Marks R. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes. 39:1990;1527-1533.
4. Austin M.A., Krauss R.M. Genetic control of low-density-lipoprotein subclasses. Lancet. 2:1986;592-595.
5. McNamara JR, Jenner JL, Li Z, Wilson PWF, Schaefer EJ. Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb. 12:1992;1284-1290.
6. Coresh J, Kwiterovich PO, Smith JHH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res. 34:1993;1687-1697.
7. Katzel LI, Krauss RM, Goldberg AP. Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. Arterioscler Thromb. 14:1994;1121-1128.
8. Feingold KR, Grunfeld C, Ping M, Doerrler W, Krauss RM. LDL subclass phenotype and triglyceride metabolism in non-insulin-dependent diabetes. Arterioscler Thromb. 12:1992;1496-1502.
9. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 106:1994;241-253.
10. Hirano T, Naito H, Kurokawa M, Ebara T, Nagano S, Adachi M, Yoshino G. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy. Atherosclerosis. 123:1996;57-72.
11. Mattock M, Morrish N, Viberti GC, Keen H, Fitzgerald A, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741.
12. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 28:1985;590-596.
13. Jensen T, Borch-Johnsen K, Kofoed-Enevoldosen A, Deckert T. Coronary heart disease in young Type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia. 30:1987;144-145.
14. Syvänne M, Talmud PJ, Humphries SE, Fisher RM, Rosseneu M, Hilden H, Taskinen M-R. Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. J Lipid Res. 38:1997;1463-1472.
15. O'Meara NM, Lewis GF, Cabana VG, Iverius PH, Getz GS, Polonsky KS. Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab. 75:1992;465-471.
16. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol. 128:1986;417-433.
17. Hatch FT, Lees RS. Practical methods for plasma lipoprotein analysis. Adv Lipid Res. 6:1968;1-68.
18. Burstein M, Scholnick HR. Lipoprotein-polyanion-metal interactions. Adv Lipid Res. 11:1973;67-108.
19. Kataoka S, Paidi M, Howard BV. Simplified isoelectric focusing/immunoblotting determination apoprotein E phenotype. Clin Chem. 40:1994;11-13.
20. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb. 13:1993;815-825.
21. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb. 13:1993;147-153.
22. Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest. 92:1993;141-146.
23. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry CP, Mayer EJ, Krauss RM. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation. 88:1993;381-387.
24. Deckelbaum RJ, Grannot E, Oschry Y, Rose L, Eisenberg S. Plasma triglyceride determines structure-composition in low and high density lipoproteins. Arterioscler Thromb. 13:1984;170-189.
25. Karpe F, Tornvall P, Olivecrona T, Steiner G, Carson LA, Hamsten A. Composition of human low density lipoprotein: effect of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis. 98:1993;33-49.
26. Tan KCB, Cooper MB, Ling KLE, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin-dependent diabetic patients with and without hypertriglyceridemia: the involvement of, insulin, insulin precursor species and insulin resistance. Atherosclerosis. 113:1995;273-287.
27. O'Neal D, Lee P, Murphy B, Best J. Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis. 27:1996;84-91.
28. Bofinger A, Westhuyzen J, Saltissi D, Morgan C, Healy H. Low-density lipoprotein subfraction profile in dialysis patients. Nephrology. 3:1997;169-177.
29. Warwick GL, Packard CJ, Stewart JP, Watson TDG, Burns L, Boulton-Jones JM, Shepherd J. Post-prandial lipoprotein metabolism in nephrotic syndrome. Eur J Clin Invest. 22:1992;813-820.
30. Griffin BA, Packard CJ. Metabolism of VLDL and LDL subclasses. Curr Opin Lipidol. 5:1994;200-206.